Stephen Liu
MD
Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Nov 30, 2023
Episode
190
Soundcloud
Share
Lung Cancer Considered host Dr. Stephen Liu moderates a discussion on the November 15, 2023, US FDA approval of repotrectinib for advanced NSCLC with a ROS1 gene fusion based on the single-arm, multi-cohort TRIDENT-1 trial.
Guest
Jessica Lin
MD
Assistant Professor of Medicine
Harvard Medical School
Belinda Termeer Center for Targeted Therapies at Massachusetts General Hospital
Benjamin Besse
MD, PhD
Director of Clinical Research
Gustave Roussy, Villejuif, France
